logo

Health Care News

Share

Incyte Q4 GAAP EPS $0.13; Non-GAAP EPS $0.62

AstraZeneca Says Forxiga Approved In EU For Treatment Of Symptomatic Chronic Heart Failure

Roche Reports Positive Results From Phase 3 COMMODORE 2 Study, Evaluating Efficacy And Safety Of Crovalimab

Viridian Therapeutics Appoints Scott Myers As President And CEO

LAVA Therapeutics Appoints Charles Morris As Chief Medical Officer